Who owns AKTS - Aktis Oncology, Inc. - Common Stock based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

Aktis Oncology, Inc. - Common Stock (AKTS) Institutional Ownership

Q: What is CUSIP 01021M104?

CUSIP 01021M104 is the security identifier used in SEC filing datasets for AKTS - Aktis Oncology, Inc. - Common Stock.

CUSIP: 01021M104

13F Institutional Holders and Ownership History

Type / Class: Equity / Common Stock
Symbol: AKTS on Nasdaq
Shares outstanding: 53,432,253
Price per share: $19.63

Investment Quick Answers

What is CUSIP 01021M104?
CUSIP 01021M104 identifies AKTS - Aktis Oncology, Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Significant Owners of Aktis Oncology, Inc. - Common Stock (AKTS) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
VV Manager II, LLC	11%				5,831,315		Helen Kim	12 Jan 2026
EcoR1 Capital, LLC	9.1%				4,862,335		Oleg Nodelman	12 Jan 2026